SS31: 5-10mg*10 vials

Introduction: SS31, also known as Bendavia, is a novel mitochondria-targeted peptide with potential therapeutic applications in various medical fields. This peptide has gained attention for its ability to protect mitochondria, the cellular powerhouses, from damage and dysfunction, thereby offering potential benefits in conditions associated with mitochondrial dysfunction and oxidative stress.

What is SS31? SS31 is a synthetic peptide designed to specifically target and protect mitochondria from damage. It belongs to a class of compounds known as mitochondria-targeted peptides (MTPs) and is engineered to penetrate cell membranes and accumulate within mitochondria, where it exerts its protective effects.

Potential Different Names:

• Bendavia
• MTP131

Chemical Formula: The chemical formula of SS31 is C33H54N6O9S2.

Structure: SS31 is a cyclic peptide composed of 31 amino acids arranged in a specific sequence. Its unique structure allows it to selectively target mitochondria and interact with mitochondrial membranes, where it exerts its protective effects.

How Does it Work? SS31 works by targeting and accumulating within mitochondria, where it interacts with mitochondrial membranes and proteins to stabilize and protect them from oxidative damage. By preserving mitochondrial function, SS31 helps maintain cellular energy production, reduce oxidative stress, and enhance cellular survival in conditions associated with mitochondrial dysfunction.

Potential Applications:

• Mitochondrial Dysfunction: SS31 shows promise as a potential therapeutic agent for various conditions characterized by mitochondrial dysfunction, including neurodegenerative diseases, cardiovascular disorders, and metabolic syndromes.
• Cardiovascular Health: SS31 may benefit individuals with heart failure, ischemic heart disease, or other cardiovascular conditions by protecting cardiac mitochondria and improving heart function.
• Neuroprotection: SS31 has neuroprotective properties and may offer benefits in neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and stroke.

Potential Side Effects:

• SS31 is generally well-tolerated in preclinical studies, with minimal reported side effects. However, potential adverse effects may include mild gastrointestinal symptoms, transient injection site reactions, or allergic reactions in sensitive individuals.

Dosage: The dosage of SS31 may vary depending on factors such as the specific medical condition being treated, patient characteristics, and the formulation of the peptide. Dosage recommendations should be determined by a qualified healthcare professional based on individual patient needs and response to treatment.

What to Check Before: Before using SS31, individuals should:

• Consult with a healthcare provider to determine if SS31 is appropriate for their specific medical condition and overall health status.
• Discuss any existing medical conditions, allergies, or medications with their healthcare provider to assess potential interactions or contraindications.
• Adhere to recommended dosage and administration instructions provided by the prescribing healthcare professional to optimize safety and efficacy.

Conclusion: SS31 represents a promising therapeutic approach for mitigating mitochondrial dysfunction and oxidative stress-related damage in various medical conditions. With its ability to target and protect mitochondria, SS31 holds significant potential for improving cellular function and enhancing overall health outcomes in individuals with mitochondrial-related disorders.

Disclaimer: SS31 is intended for research and experimental purposes only and has not been approved for clinical use by regulatory agencies. This product description is provided for informational purposes and should not be construed as medical advice. Individuals considering SS31 or any other experimental therapy should consult with a qualified healthcare professional before use.